Skip to main content
Lareb logo Menu icon
  • News updates
  • Publications and overviews
  • Education and patient reporting
  • Teratology Information Service (TIS)
  • About Lareb
  • Research and collaborations
  • Contact
Lareb logo
  • About Lareb
  • Contact
Menu icon
Meld een bijwerking van een:
/media/1auhenje/banner-homepage-2.png
  • Home
  • News updates
  • ADR associated change of package of Thyrax (levothyroxine)

ADR associated change of package of Thyrax (levothyroxine)

23-02-2015

In the autumn of 2014 Lareb detected a signal concerning ADRs of levothryroxine (brand name Thyrax) which occurred after the packaging change from a glass bottle to an aluminum blister. The majority of the ADRs concern symptoms associated with hyperthyroidism such as palpitations, hyperhidrosis and agitation. Levothyroxine is sensitive to environmental factors. It may be possible that the tablet in the bottle package, over time, contained a lower dose of levothyroxine compared to tablet in the blister package, due to environmental factors. This may explain the above described reactions.

Since raising the signal, the Medicines Evaluation Board has informed doctors, pharmacist and patients about this problem through a DHPC. There has also been attention in the national media. After a TV broadcast Lareb received more than 2.500 additional reports. In order to evaluate this signal further, Lareb is conducting additional research.

Pharmacovigilance Centre Lareb
  • About Lareb
  • Research and collaborations
  • Contact
Search
  • News updates
  • Publications and overviews
More about
  • Education and patient reporting
  • Teratology Information Service (TIS)
logo
© Lareb. All Rights Reserved. 2025
Dutch | Cookies | Privacy | Disclaimer
Pharmacovigilance Centre Lareb
  • About Lareb
  • Research and collaborations
  • Contact
Search
  • News updates
  • Publications and overviews
More about
  • Education and patient reporting
  • Teratology Information Service (TIS)
logo
© Lareb. All Rights Reserved. 2025
Dutch | Cookies | Privacy Disclaimer

Dat spijt ons. Kun je ons vertellen wat er niet werkte voor jou?

Toelichting